<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
        <PMID Version="1">21217927</PMID>
        <DateCreated>
            <Year>2011</Year>
            <Month>01</Month>
            <Day>10</Day>
        </DateCreated>
        <DateCompleted>
            <Year>2011</Year>
            <Month>07</Month>
            <Day>14</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2013</Year>
            <Month>05</Month>
            <Day>29</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2092-7363</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>3</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2011</Year>
                        <Month>Jan</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Allergy, asthma &amp; immunology research</Title>
                <ISOAbbreviation>Allergy Asthma Immunol Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>In vitro Biphasic Effect of Honey Bee Venom on Basophils from Screened Healthy Blood Donors.</ArticleTitle>
            <Pagination>
                <MedlinePgn>58-61</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.4168/aair.2011.3.1.58</ELocationID>
            <Abstract>
                <AbstractText>Apis mellifera L. bee venom is the most studied hymenoptera allergen, but many aspects of its action on human basophils remain unclear. Allergologists seek evidence of the effectiveness of bee venom immunotherapy as this approach is the chosen treatment for systemic allergic reactions. The effect of bee venom on human basophils in vitro has not been studied in detail for many reasons, including the paucity of basophils in peripheral blood, inter-individual basophil response variability, and the reliability and predictability of basophil activation tests. We conducted a brief preliminary survey of the effect of Apis bee venom on healthy asymptomatic (non-allergic) subjects. A dose of an aqueous commercial extract of Apis bee venom as high as 10 Âµg/mL activated resting basophils (CD63=+80-90%, CD203c=+30%), while it inhibited the expression of CD63 (-50%) following basophil stimulation by the soluble agonists formyl-Met-Leu-Phe or anti-IgE. The activation of resting basophils appeared to be dose-related. Only when basophils were activated with an IgE-mediated agonist, did bee venom extract exhibit a possible priming mechanism at the lowest doses used only via CD63, while it was ineffective via CD203c. Autocrine interleukin-3 may play a role in the observed biphasic behavior.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Chirumbolo</LastName>
                    <ForeName>Salvatore</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Pathology and Diagnostics, University of Verona, Verona, Italy.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zanoni</LastName>
                    <ForeName>Giovanna</ForeName>
                    <Initials>G</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ortolani</LastName>
                    <ForeName>Riccardo</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vella</LastName>
                    <ForeName>Antonio</ForeName>
                    <Initials>A</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2010</Year>
                <Month>11</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Korea (South)</Country>
            <MedlineTA>Allergy Asthma Immunol Res</MedlineTA>
            <NlmUniqueID>101518382</NlmUniqueID>
            <ISSNLinking>2092-7355</ISSNLinking>
        </MedlineJournalInfo>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Exp Allergy. 1993 Nov;23(11):901-10</RefSource>
                <PMID Version="1">10779277</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cytometry B Clin Cytom. 2010 Sep;78(5):308-18</RefSource>
                <PMID Version="1">20533392</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Opin Allergy Clin Immunol. 2004 Aug;4(4):291-5</RefSource>
                <PMID Version="1">15238795</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2009 Feb 15;182(4):2432-8</RefSource>
                <PMID Version="1">19201898</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Dtsch Dermatol Ges. 2010 Feb;8(2):114-27; quiz 128-30</RefSource>
                <PMID Version="1">19751222</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Allergy Clin Immunol. 2010 Aug;126(2):375-83</RefSource>
                <PMID Version="1">20624641</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunol Lett. 2004 Aug 15;95(1):37-44</RefSource>
                <PMID Version="1">15325796</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Allergy Asthma Proc. 2006 Mar-Apr;27(2):151-8</RefSource>
                <PMID Version="1">16724636</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Exp Allergy. 2007 Nov;37(11):1668-75</RefSource>
                <PMID Version="1">17868401</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Exp Immunol. 2008 Jan;151(1):94-100</RefSource>
                <PMID Version="1">18005261</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Allergy Clin Immunol. 2008 Jun;121(6):1500-6, 1506.e1-4</RefSource>
                <PMID Version="1">18539198</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Mol Allergy. 2008;6:12</RefSource>
                <PMID Version="1">18925959</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Wien Klin Wochenschr. 2009;121(9-10):357-60</RefSource>
                <PMID Version="1">19562302</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Drug News Perspect. 2009 Apr;22(3):146-50</RefSource>
                <PMID Version="1">19440557</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cytometry B Clin Cytom. 2010 Sep;78(5):302-7</RefSource>
                <PMID Version="1">20533388</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Int Arch Allergy Immunol. 2002 Oct;129(2):160-8</RefSource>
                <PMID Version="1">12403934</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC3005321</OtherID>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">CD203c</Keyword>
            <Keyword MajorTopicYN="N">CD63</Keyword>
            <Keyword MajorTopicYN="N">Honey bee venom allergy</Keyword>
            <Keyword MajorTopicYN="N">basophil activation</Keyword>
            <Keyword MajorTopicYN="N">flow cytometry</Keyword>
            <Keyword MajorTopicYN="N">immunotherapy</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2010</Year>
                <Month>8</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2010</Year>
                <Month>9</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2010</Year>
                <Month>11</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2011</Year>
                <Month>1</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2011</Year>
                <Month>1</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2011</Year>
                <Month>1</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.4168/aair.2011.3.1.58</ArticleId>
            <ArticleId IdType="pubmed">21217927</ArticleId>
            <ArticleId IdType="pmc">PMC3005321</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
